G6PD (IU/g Hb) group | Total | p-value | |||
---|---|---|---|---|---|
Normal 6.4–18.7 | Deficiency < 6.4 | Increased > 18.7 | |||
Age group (years) | |||||
12–14 | 17 (85%) | 3 (15%) | 0 (0%) | 20 | 0.745 |
15–29 | 26 (86.7%) | 2 (6.7%) | 2 (6.7%) | 30 | |
30–44 | 18 (90%) | 1 (5%) | 1 (5%) | 20 | |
45–60 | 14 (82.4%) | 3 (17.6%) | 0 (0%) | 17 | |
≥ 60 | 11 (84.6%) | 2 (15.4%) | 0 (0%) | 13 | |
Gender | Normal | Deficiency | Increased | ||
Male | 39 (45.3%) | 9 (81.8%) | 1 (33.5%) | 49 | 0.053 |
Female | 47 (54.7%) | 2 (18.2%) | 2 (66.7%) | 51 | |
Region (Province no. 5) | Normal | Deficiency | Increased | ||
Nawalparasi | 18 (20.9%) | 2 (18.2%) | 0 (0%) | 20 | 0.406 |
Rupandehi | 17 (19.8%) | 1 (9.1%) | 0 (0%) | 18 | |
Kapilvastu | 19 (22.1%) | 1 (9.1%) | 0 (0%) | 20 | |
Dang | 16 (18.6%) | 4 (36.4%) | 1 (33.3%) | 21 | |
Bheri | 16 (18.6%) | 3 (27.3%) | 2 (66.7%) | 21 | |
Diagnosis | Normal | Deficiency | Increased | ||
Normal | 35 (97.2%) | 1 (2.8%) | 0 (0%) | 36 | 0.063 |
SCT | 29 (76.3%) | 7 (18.4%) | 2 (5.3%) | 38 | |
SCA | 3 (60%) | 2 (40%) | 0 (0%) | 5 | |
β-TT | 19 (90.5%) | 1 (4.8%) | 1 (4.8%) | 21 | |
Anemia (WHO criteria) | Normal | Deficiency | Increased | ||
Normal [> 13 (M), > 12 (F) g/dl] | 7 (100%) | 0 (0%) | 0 (0%) | 7 | 0.574 |
Mild [11–12.9 (M) 11–11.9 (F) g/dl] | 22 (84.6%) | 4 (15.4%) | 0 (0%) | 26 | |
Moderate [8–10.9 (M/F) g/dl] | 42 (82.4%) | 6 (11.8%) | 3 (5.9%) | 51 | |
Severe [< 8 (M/F) g/dl) | 15 (93.8%) | 1 (6.3%) | 0 (0%) | 16 |